Skip to content
Maui Sky – Lifestyle
Author:
Fractyl Health, Inc.
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
June 4, 2026
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
June 1, 2026
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
May 12, 2026
Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
May 11, 2026
Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
May 5, 2026
←
Previous Page
1
2